|
|
|
| Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali | Discover the future of cardiac care on Cell & Gene: The Podcast as host Erin Harris speaks with Faraz Ali, CEO of Tenaya Therapeutics. They dive into groundbreaking gene therapies for heart disease, Tenaya’s innovative platform, and their in-house manufacturing capabilities. Ali shares insights on commercialization challenges, industry trends, and what’s ahead for Tenaya in 2025. Tune in for a fascinating look at how gene therapy is transforming heart disease treatment. |
|
|
|
|
Tax policy shifts can directly affect corporate structure decisions, overall business strategy, and the ability to allocate resources effectively. In 2025, staying ahead of these changes will be vital, writes life sciences tax expert Richard Weiner. |
|
|
|
| Delivering Genetic Editing Therapies To Market | Manufacturers with proven expertise in areas like viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients. |
|
|
| How FAIR Data Principles Deliver Clinical Success | Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being. |
|
|
|
|
